<--- Back to Details
First PageDocument Content
Medicine / Rheumatology / Clinical medicine / Inborn errors of purine-pyrimidine metabolism / Uric acid / Pegloticase / Gout / Urate oxidase / Hyperuricemia / PEGylation / Tophus / ULT
Date: 2016-07-11 16:59:27
Medicine
Rheumatology
Clinical medicine
Inborn errors of purine-pyrimidine metabolism
Uric acid
Pegloticase
Gout
Urate oxidase
Hyperuricemia
PEGylation
Tophus
ULT

Microsoft Word - Savient Press Release ACRdoc

Add to Reading List

Source URL: www.mvpharm.com

Download Document from Source Website

File Size: 35,61 KB

Share Document on Facebook

Similar Documents

ORIGINAL ARTICLE Clinical Implications of Molecular PEGylation on Therapeutic Proteins Nandhakumar Sathyamoorthy, Dhanaraju Dasaratha Magharla Department of Pharmaceutics, GIET School of Pharmacy, Rajahmundry, Andhra Pr

DocID: 1uHNe - View Document

Chemistry / Medicine / Clinical medicine / Biotechnology / Inborn errors of purine-pyrimidine metabolism / Uric acid / Excipients / PEGylation / Pharmacokinetics / Pegloticase / Urate oxidase / Gout

Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1 Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1

DocID: 1rrGr - View Document

Chemistry / Medicine / Clinical medicine / Excipients / Inborn errors of purine-pyrimidine metabolism / Uric acid / Biotechnology / PEGylation / Pharmacokinetics / Pegloticase / Urate oxidase / Polyethylene glycol

Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1 Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1

DocID: 1rrm1 - View Document

Medicine / Rheumatology / Clinical medicine / Inborn errors of purine-pyrimidine metabolism / Uric acid / Pegloticase / Gout / Urate oxidase / Hyperuricemia / PEGylation / Tophus / ULT

Microsoft Word - Savient Press Release ACRdoc

DocID: 1rrcY - View Document

Medicine / Biotechnology / PEGylation / Pharmacokinetics / Pegloticase / Savient pharmaceuticals / Biology / Health / Urate oxidase / Gout / Uric acid / Pharmaceutical industry in China

Microsoft Word - Savient Phase 3 Dosing press releasedoc

DocID: 1ri7E - View Document